George Hucks

509 total citations
11 papers, 359 citations indexed

About

George Hucks is a scholar working on Oncology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, George Hucks has authored 11 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in George Hucks's work include CAR-T cell therapy research (9 papers), Acute Lymphoblastic Leukemia research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). George Hucks is often cited by papers focused on CAR-T cell therapy research (9 papers), Acute Lymphoblastic Leukemia research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). George Hucks collaborates with scholars based in United States, Germany and Canada. George Hucks's co-authors include Susan R. Rheingold, Diane Baniewicz, Colleen Callahan, David T. Teachey, Simon F. Lacey, Stephan A. Grupp, Carl H. June, Shannon L. Maude, David L. Porter and Vanessa Gonzalez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cell Cycle.

In The Last Decade

George Hucks

11 papers receiving 354 citations

Peers

George Hucks
Zhuojun Ling China
Xiaoqian Liang China
Wenli Zhang China
Yaohui Wu China
Rajat K. Das India
Ira L. Kraft United States
Jean‐Marc Hoffmann Germany
Patricia Steinert United States
Yanzhi Song China
Kathleen Ruehle United States
Zhuojun Ling China
George Hucks
Citations per year, relative to George Hucks George Hucks (= 1×) peers Zhuojun Ling

Countries citing papers authored by George Hucks

Since Specialization
Citations

This map shows the geographic impact of George Hucks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Hucks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Hucks more than expected).

Fields of papers citing papers by George Hucks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Hucks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Hucks. The network helps show where George Hucks may publish in the future.

Co-authorship network of co-authors of George Hucks

This figure shows the co-authorship network connecting the top 25 collaborators of George Hucks. A scholar is included among the top collaborators of George Hucks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Hucks. George Hucks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cheng, Catherine, John B. West, Fiona Buchanan, et al.. (2025). 141 | CD30 CAR‐T IN RELAPSED AND REFRACTORY CD30+ LYMPHOMAS: LONG‐TERM FOLLOW‐UP OF A PHASE IB/II CLINICAL TRIAL. Hematological Oncology. 43(S3). 1 indexed citations
2.
Voorhees, Timothy, Anne Beaven, Christopher Dittus, et al.. (2022). Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma. Blood. 140(Supplement 1). 12723–12724. 4 indexed citations
3.
Hucks, George, Barbara Savoldo, Gianpietro Dotti, et al.. (2021). CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and Non-Hodgkin Lymphoma in Pediatric Patients. Blood. 138(Supplement 1). 2829–2829. 6 indexed citations
4.
Voorhees, Timothy, Jorge D. Oldan, George Hucks, et al.. (2021). Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma. Blood Advances. 6(4). 1255–1263. 36 indexed citations
5.
6.
Hucks, George & Susan R. Rheingold. (2019). The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL. Blood Cancer Journal. 9(2). 10–10. 62 indexed citations
7.
Li, Amanda M., George Hucks, Amanda M. DiNofia, et al.. (2018). Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia. Blood. 132(Supplement 1). 556–556. 121 indexed citations
8.
Talekar, Mala K., Shannon L. Maude, George Hucks, et al.. (2017). Effect of chimeric antigen receptor-modified T (CAR-T) cells on responses in children with non-CNS extramedullary relapse of CD19+ acute lymphoblastic leukemia (ALL).. Journal of Clinical Oncology. 35(15_suppl). 10507–10507. 15 indexed citations
9.
Maude, Shannon L., George Hucks, Alix E. Seif, et al.. (2017). The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL).. Journal of Clinical Oncology. 35(15_suppl). 103–103. 79 indexed citations
10.
Mueller, Emily L., F. Jacob Seagull, Kelly Walkovich, et al.. (2016). Making Improvements in the ED. Pediatric Emergency Care. 34(5). 310–316. 8 indexed citations
11.
Kenneth, Niall S., et al.. (2014). Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways. Cell Cycle. 13(6). 1006–1014. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuojun Ling Breakdown of academic impact, for papers by Xiaoqian Liang Breakdown of academic impact, for papers by Wenli Zhang Breakdown of academic impact, for papers by Yaohui Wu Breakdown of academic impact, for papers by Rajat K. Das Breakdown of academic impact, for papers by Ira L. Kraft Breakdown of academic impact, for papers by Jean‐Marc Hoffmann Breakdown of academic impact, for papers by Patricia Steinert Breakdown of academic impact, for papers by Yanzhi Song Breakdown of academic impact, for papers by Kathleen Ruehle
Rankless by CCL
2026